I received my Master Degree in Molecular Biotechnology in 2007 from Alma Mater Studiorum Bologna University, Italy. I then moved to the Karolinska Institutet where I received my PhD in 2012. In 2013 I joined the laboratory of Dr. Steven Rosenberg as post-doctoral fellow at the National Cancer Institute, NIH and my research was focused on the isolation of TCR genes from mutation-reactive tumor infiltrating lymphocytes in metastatic solid cancers.
Since 2018, I worked at the Karolinska Institutet as Assistant Professor and Managing Director of the pre-GMP facility in the Department of Laboratory Medicine, where I am still affiliated to this day as research specialist.
In 2022 I joined the Oslo University Hospital as Director of the Center for Advanced Cell Therapy (ACT) and also the University of Oslo as Associate Professor.
My professional goal is to facilitate and support the development of new immunotherapies against cancer.